# Liposomal Bupivacaine in Total Knee Arthroplasty

> **NCT02426164** · PHASE4 · WITHDRAWN · sponsor: **Miller Orthopedic Specialists**

## Conditions studied

- Pain, Postoperative
- Arthroplasty, Replacement, Knee
- Osteoarthritis

## Interventions

- **DRUG:** Liposomal bupivacaine
- **DRUG:** bupivacaine HCl, morphine, epinephrine, methylprednisolone

## Key facts

- **NCT ID:** NCT02426164
- **Lead sponsor:** Miller Orthopedic Specialists
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-06
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Could not receive facility approval
- **Last updated:** 2016-03-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02426164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02426164, "Liposomal Bupivacaine in Total Knee Arthroplasty". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02426164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*